Background. Studies exploring the impact of overweight on mortality have reported controversial results in dialysis patients; some have found overweight to increase mortality, whereas others suggest that it offers a survival advantage. We conducted a prospective study to evaluate the impact of overweight on atherosclerotic events (AE) in dialysis patients with special respect to the malnutrition/inflammation complex syndrome (MICS). Methods. Five hundred and forty-one hemodialysis patients from 11 dialysis centers in France were included. A number of baseline parameters including traditional and nontraditional cardiovascular (CV) risk factors were measured and the cohort was followed prospectively. Results. Over a mean follow-up of 39 months, 207 patients (38.3%) experienced an AE. Overweight, defined by a body mass index greater than 25 kg/m
A B S T R AC T
Background. Studies exploring the impact of overweight on mortality have reported controversial results in dialysis patients; some have found overweight to increase mortality, whereas others suggest that it offers a survival advantage. We conducted a prospective study to evaluate the impact of overweight on atherosclerotic events (AE) in dialysis patients with special respect to the malnutrition/inflammation complex syndrome (MICS). Methods. Five hundred and forty-one hemodialysis patients from 11 dialysis centers in France were included. A number of baseline parameters including traditional and nontraditional cardiovascular (CV) risk factors were measured and the cohort was followed prospectively. Results. Over a mean follow-up of 39 months, 207 patients (38.3%) experienced an AE. Overweight, defined by a body mass index greater than 25 kg/m 2 , was associated with increased risk of AEs [RR: 1.68 (CI: 1.11-3.56)], and CV mortality [RR: 1.51 (CI: 1.07-2.13)]. The effect of overweight was different in patients with and without MICS. Age, diabetes, a previous history of CV disease, high serum levels of homocysteine and MICS were also associated with an increased risk of AEs.
Conclusions. Similar to the general population, overweight contributes to an increased risk for AEs and CV mortality in hemodialysis patients. The presence or absence of MICS can modify the impact of overweight on development of AEs and mortality in this population.
I N T RO D U C T I O N
Chronic hemodialysis patients have disproportionately high rates of atherosclerotic complications and cardiovascular (CV) mortality [1] . A high prevalence of both traditional and nontraditional CV risk factors is likely to account for this increased incidence of atherosclerotic complications. Several of these risk factors are interrelated and it is difficult to assess the relevance of each of them independently. Moreover, a number of studies indicate that, in contrast to the general population, a number of CV risk factors are indeed correlated with a decreased risk of atherosclerotic events (AE) in the dialysis population [2] . Subsequently, the concept of 'reverse epidemiology' in hemodialysis emerged to explain the apparent protective effects of these so-called traditional CV risk factors [2] .
Overweight represents one of the most prominent patterns of this paradox; while a large number of epidemiological studies have shown a strong relationship between obesity and increased risk of CV disease and mortality in the general population [3] [4] [5] , a low body mass index (BMI) has consistently been found to be a strong predictor of increased mortality in dialysis patients [6] [7] [8] . However, a more recent study found obesity to be associated with an increased risk of death in dialysis patients [9] . Interestingly, the dialysis population and the control group with comparable age and duration of follow-up showed similar mortality risk patterns related to BMI in that study [9] . This finding stands against the phenomenon of 'reverse epidemiology' for BMI in dialysis patients.
Little is known about the impact of overweight on AE in the dialysis population. We conducted this prospective multicenter study on chronic dialysis patients in three regions of France to specifically explore the impact of overweight on AE and mortality in this population with respect to other known CV risk factors.
M AT E R I A L S A N D M E T H O D S

Patient characteristics
Participants in the study were recruited from 11 dialysis centers in Bourgogne (Dijon, Macon, Chalon sur Saone, Auxerre, Sens), Franche-Comté (Besançon, Montbéliard, Vesoul, Dole) and Bresse (Bourg-en-Bresse). All stable endstage renal disease patients who were on chronic hemodialysis for more than 3 months and did not have any acute illness were included in this study.
Cardiovascular risk factors
Age, gender, weight, size, blood pressure (BP), duration of weekly hemodialysis session, duration of dialysis, diabetes mellitus, smoking history, past history of CV events and various relevant laboratory parameters were assessed upon inclusion. C-reactive protein (CRP) was measured by nephelometry (Kit Beckman, Behringwerke AG, Marburg, Germany).
A past history of CV events was defined by the following:
(i) Coronary heart disease: documented myocardial infarction, coronary revascularization including coronary artery bypass surgery or percutaneous transluminal coronary angioplasty and typical history of angina associated with abnormal findings on coronary angiograhy or myocardial scintigraphy; (ii) Cerebrovascular disease: both non-hemorrhagic and hemorrhagic cerebrovascular accidents, as well as carotid endarterectomy;
(iii) Abdominal aortic or lower-extremity arterial disease: abdominal aortic surgery, lower extremity amputation, intermittent claudication associated with abnormal findings on Doppler ultrasound or arteriography Nutritional status was assessed using serum albumin and BMI. BMI was calculated (weight/size 2 ) as well as normalized protein catabolic rate (nPCR). Subjects were categorized as current smokers or non-smokers. A past history of smoking was also assessed. BP was measured using a semi-automatic device, based on an oscillometric method with the patients in a sitting position after resting for more than 5 min. Mean [diastolic BP + 1/3(systolic BP-diastolic BP)] and pulse pressure (systolic BP -diastolic BP) were calculated.
Concerning residual renal function, patients were categorized into two groups based on daily urine output (<500 or ≥500 mL).
A past history of parathyroidectomy was also looked for through review of medical records. Intact parathyroid hormone (iPTH) was measured using an immunoradiometric assay, with a normal range between 15 and 80 pg/mL.
Homocysteine
Total plasma homocysteine (tHcy) concentration was measured using a previously described method [10] . In brief, venous blood samples were drawn after an overnight fasting. The blood sample was centrifuged within 15 min, and plasma stored frozen at -20°C. Hcy concentration, the sum of the acid-soluble (that is reduced Hcy, homocystine disulphide and homocysteine-cysteine mixed disulphide), and protein-bound moieties were measured by high-performance liquid chromatography. This assay involves the following steps: reduction of the sample with tri-n-butylphosphine, precipitations of proteins, alkalinization of the supernatant with sodium borate, derivitization with 7-fluoro-2-oxa-1,3 diazole-4 sulphonate, followed by 8-aminonaphtalene-1,3,6-trisulphonic acid and HPLC separation with fluorescence detection. The normal values of plasma Hcy concentration ranged from 7 to 15 μmol/L. The precision of the assay corresponds to a coefficient of variation of less than 3%.
Atherosclerotic events
Coronary heart disease (CHD). Myocardial infarction documented by serial 12-lead electrocardiogram evidence or Q-wave infarction and appropriate myocardial enzyme elevations; coronary revascularization including coronary artery bypass surgery or percutaneous transluminal coronary angioplasty; typical history of angina with abnormal coronarography.
Stroke/cerebrovascular disease. Both non-hemorrhagic and hemorrhagic strokes confirmed by neurological examination findings consistent with new onset focal neurologic deficits, with or without computed tomography or magnetic resonance imaging evidence of cerebral infarction; symptomatic extracranial artery stenosis resulting in carotid endarterectomy.
Abdominal aortic or lower extremity arterial disease. Abdominal aortic repair; lower extremity revascularization via bypass surgery or angioplasty; lower extremity amputation; new onset of intermittent claudication confirmed by Doppler ultrasound or arteriographic findings.
Two physicians independent of the study were responsible for evaluation of CV events. This analysis was performed without the knowledge of the baseline characteristics.
Statistical analysis
Arithmetic mean was calculated and expressed as ±SD. Using log-rank tests on Kaplan-Meier non-parametric estimates of the survival without AE distribution, we selected variables with a P-value lower than, or equal to, 0.20. The selected variables were included in a Cox proportional hazards model, and a backward stepwise selection process was performed, this time at a classical α = 0.05. The time elapsed since dialysis initiation was found to vary between patients; therefore, this duration was forced into the Cox model as a covariate. We also conducted analysis without adjustment for dialysis duration. Patients were classified as underweight (BMI < 18.5 kg/m 2 ), standard weight (BMI ≥ 18.5 and ≤25 kg/m 2 ) or overweight (BMI > 25 kg/m 2 ). Age was split into tertiles (<62, 62-72, ≥73) as well as tHcy (≤24, 25-30, >30 μmol/L). Tobacco consumption was accounted for as current smoker versus non-smoker. To distinguish individuals with any evidence of malnutrition/ inflammation complex syndrome (MICS), a composite variable combining serum albumin and CRP was used to categorize the study population into two subgroups. The presence of MICS was defined as achievement of a priori cutoffs for any of the two variables from previously reported studies [11] . For serum albumin levels, the cutoff was less than 36 g/L and for CRP, it was 10 mg/L or higher. CRP and albumin were first entered separately as continuous variables in the statistical model, and then as a composite parameter.
Statistical analysis used the Statview 5.0 software.
R E S U LT S
Demographic characteristics
The characteristics of the study population have previously been described in details [10] and are summarized in Tables 1  and 2 . Five hundred forty-one patients were included in the study and were followed for a mean duration of 39 ± 6 months. The study population composed mainly of Caucasians (95%), followed by blacks (4%) and Asians (1%). Mean dialysis duration before entering into the study was 40 ± 34 months. Forty patients (7.3%) underwent renal transplantation during the follow-up. These patients' data entered into analysis until the date of transplant.
Overall, 49.7% (n = 269) of the patients had evidence of MICS. Presence of MICS was associated with older age, past history of CV disease, diabetes and lower tHcy. BMI was not different between the two populations (24.2 ± 4.8 versus 24.2 ± 4.3 kg/m 2 ; P = 0.49). Three hundred and one patients (55.6%) had normal weight, 201 (37.2%) were overweight and 39 (7.2%) were underweight. In those overweight, 40 were obese (7.4%). The characteristics of the three groups are depicted in Tables 1 and  2 . Underweight patients were more frequently women, were younger and had lower BP. The proportion of diabetic patients increased linearly with BMI. Except for the proportion of diabetic patients, overweight patients were not different from those with normal weight for any characteristics.
Atherosclerotic events
Only the first event in every patient was withheld in the statistical analysis. Over a mean follow-up of 39 months, 207 patients (38.3%) experienced an AE (cerebrovascular disease, 36; coronary heart disease, 94; peripheral vascular disease, 77). This corresponds to 118 AE for 1000 patients-year.
BMI was higher in patients who experienced AE (24.6 ± 4 versus 23.6 ± 3.9 kg/m 2 ; P < 0.0001). The rate of AE was higher in overweight patients [51 versus 38% in underweight (P = 0.035) and 34% in standard weight patients (P = 0.004)]. Figure 1 provides the distribution of BMI in the cohort overall and among patients with and without events.
In univariate analysis, age (P < 0.0001), male gender (P = 0.02), a past history of CV disease (P < 0.0001), overweight (P = 0.004), smoking (P = 0.11), diabetes (P = 0.03), high pulse pressure (P = 0.03), tHcy (P = 0.01), CRP (<0.0001) and albumin (P = 0.002) were associated with AE. However, since the number of AE was high (n = 207), we consider the risk of 'overfitting' to be low. Moreover, the variables under study were likely to be interrelated. Hence, we decided to include all variables into the model.
After backward stepwise selection, the variables which remained in the Cox proportional hazards model, i.e. which were linked to AE with P values <0.05, were age, MICS, a past history of AE, diabetes, tHcy and BMI.
Cox regression analysis revealed that age in the higher tertile (HR 2.75; 95% CI 1.42-5.29), diabetes (HR 1.52; 95% CI 1.14-3.12), albumin (HR 1.67; 95% CI 1.22-4.21 for every 1 g/L decrease in serum level), CRP (HR 1.54; 95% CI 1.15-5.32 for every 1 mg/dL increase in serum level), a previous history of CV disease (HR 1.65; 95% CI 1.36-4.07), BMI over 25 kg/m 2 (HR 1.26; 95% CI 1.04-1.54) and tHcy in the higher tertile (HR 1.67; 95% CI 1.21-2.26) were all risk factors for AE (Table 3) . Assumptions of Cox models (log-linearity, proportionality of risk in time) were met in this analysis. Relative risks and their 95% confidence intervals (95% CI) of AE for each variable in the Cox model are displayed in Table 3 , along with P values. When CRP and albumin were replaced by a composite variable (i.e. MICS), the same variables remained independently associated with AE. In this model, MICS was also associated with AE (HR 4.23; 95% CI 2.36-9.21). Due to the high prevalence of diabetes in patients with a higher BMI, we sought to explore whether the effect of BMI on AE is independent of the presence of diabetes. We did not observe any interaction between these parameters in the overweight patients: HR 1.31; 95% CI 1.06-1.67 (unadjusted), HR 1.27; 95% CI 1.04-1.58 (adjusted for the presence/absence of diabetes) and HR 1.26; 95% CI 1.04-1.54 (fully adjusted). These results suggest that the relationship between BMI and AE in the overweight patients was independent of the presence or absence of diabetes. Finally, to assess competing risk of death in the survival analysis, we studied a combined end-point associating AE or death (307 events). Overweight remained predictive of this composite end-point (HR 1.33; 95% CI 1.08-1.69; P = 0.024).
Influence of MICS
There was no significant interaction between body weight and MICS for the prediction of AE in the overall population. Indeed, MICS did not modify the hazard ratio of overweight for AE. However, the relationship between weight and AE was not similar in patients with and without MICS. Whereas, this relationship was found to be linear in patients without MICS, a U-curve better described the relationship between weight and AE in patients with MICS. Indeed, the cumulative incidence of AE in patients with underweight, normal weight and overweight was 26, 30 and 42% in those without MICS and 50, 39 and 60% in those with MICS, respectively (Figures 2  and 3 ). While the HR of overweight was not different in patients with or without MICS, the impact of underweight was different in these two groups of patients (Table 4) .
Death
Two hundred and ten patients (38.9%) died during the follow-up, and 123 (58%) of CV disease. Of note, while overweight did not predict overall mortality, it was significantly associated with an increased risk of CV death (HR 1.47; 95% CI 1.05-2.02). Although these results imply that non-CV mortality might have been lower in the overweight patients, we did not find any difference in the non-CV mortality between the two groups (HR 1.07; 95% CI 0.61-1.89).
D I S C U S S I O N
Atherosclerotic complications are frequent among dialysis population. In our patients, the cumulative risk for developing AE was 11.8% within 1 year. Both traditional and non-traditional CV risk factors are very prevalent in this population and this study, similar to previous reports, suggests that these risk factors account for the increased incidence of AE in patients with end-stage renal disease.
The major finding of this study is that overweight can predict atherosclerotic outcomes in dialysis patients. An increasing body of evidence exists on the strong relationship between obesity and increased risk of CV disease as well as mortality in the general population [3] [4] [5] . Paradoxically, a number of studies have consistently found low BMI, and not PTH, parathyroid hormone; tHcy, total serum homocysteine level; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; nPCR, normalized protein catabolic rate; CRP, C-reactive protein.
F I G U R E 1 : Distribution of BMI in the cohort overall and among patients with and without AEs.
overweight, to be a strong predictor of increased mortality in dialysis patients [6] [7] [8] . Moreover, higher BMI, either expressed as mild-to-moderate overweight or obesity, has generally not been associated with an increase in mortality risk, except in a few reports [12, 13] . For instance, Leavey et al. [7] in a study on 3607 hemodialysis patients reported that low BMI was independently and significantly predictive of increased mortality over a 5-year follow-up. Another recent study by Port et al. [14] , based on data from 45 967 incident hemodialysis patients, found that the lowest BMI group of dialysis patients had a 42% higher mortality risk compared with the highest BMI tertile. The prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) also found a decreased risk of death with increasing BMI among 9714 hemodialysis patients in the USA and Europe [15] . On the other hand, deleterious effects of a high BMI in dialysis patients have only rarely been reported. Kaizu et al. [12] in a study on 116 non-diabetic hemodialysis patients found that those with a BMI of higher than 23 kg/m 2 had a shortened survival compared with those with a BMI of 17-18.9 kg/m 2 . Our study supports the findings of the NECOSAD study group recently published [9] , indicating that, similar to the general population, obesity increases the mortality risk in dialysis patients.
The paradoxical impact of weight on outcomes reported in the above-mentioned studies represents a typical aspect of the 'reverse epidemiology' where a number of well-recognized CV risk factors in the general population (e.g. hypertension, hypercholesterolemia and hyperhomocysteinemia) appear to be protective in dialysis patients. Some authors have suggested that MICS can explain this epidemiologic phenomenon [2] . Indeed, it has been shown that MICS, which is associated with lower BMI, BP and serum lipid levels, significantly increases the risk of CV morbidity and mortality. Consequently, it has been speculated that overweight, hypertension and hyperlipidemia might offer CV protection in dialysis population. In contrast to previous reports, we did not find any significant relationship between weight and MICS in dialysis patients. This may be explained by the fact that overweight can promote inflammation through pro-inflammatory adipocytokines, while MICS per se can favor weight loss. Therefore, both overweight and underweight might be seen in association with inflammation and high CRP levels. Several factors can explain why the impact of MICS on CV outcomes is different in our study compared with previous reports. First, in contrast to most previous studies, our study population did not suffer from a selection bias and included the whole cohort of chronic dialysis population in the abovementioned regions of France. Whether the phenotype of our study population has been different from that of other studies is difficult to assess. However, inclusion of patient categories excluded from other studies could potentially have affected the results. Second, survival bias may eventually explain, at least in part, the phenomenon of 'reverse epidemiology'. It is noteworthy that incident patients with more risk factors did not survive enough to be included in prospective studies or were excluded from the analysis because of a too short life expectancy [16] . Survival bias can potentially exert a strong influence on both epidemiologic studies and clinical trials, especially when patients with varying duration of dialysis are enrolled and analyzed together. Therefore, in our study, dialysis duration was forced into the model to persistently adjust our results for this confounding variable. Third, our study has a longer follow-up compared with the majority of studies reporting a 'reverse epidemiology' phenomenon. Since MICS is the main cause of early death after initiation of dialysis, shorter follow-up might have accentuated the already existing survival bias and the consequences of the time-competition effect between risk factors leading to attenuation of the impact of traditional CV risk factors.
We analyzed the role of BMI with respect to numerous confounding factors including inflammatory (e.g. albumin and CRP) and nutritional (e.g. nPCR) parameters. Complex interactions exist between weight and the MICS. While inflammation and malnutrition can favor weight loss, overweight and obesity are associated with significant inflammation [17, 18] . Therefore, these factors cannot be analyzed independently and separately. However, the relationship between weight and AE does not seem to be similar in patients with and without MICS. Whereas this relationship was found to be linear in patients without MICS, a U-curve better described the relationship between weight and AE in patients with MICS. Accordingly, we showed that underweight is a protective factor in patients without MICS and a deleterious factor in those with MICS. In contrast, the HR associated with overweight was similar in patients with and without MICS, suggesting that MICS does not significantly interact with the proper effect of overweight. It can be suspected that underweight due to MICS-induced weight loss is a risk factor for AE, whereas constitutive underweight without MICS is a protective factor.
There are limitations to our study. We evaluated the influence of a baseline BMI and other factors on the occurrence of AE in a population of prevalent dialysis patients. Serial measurements of these parameters in a longitudinal cohort design would certainly have provided a more precise estimate of CV risk in this population. Besides, some well-recognized CV risk factors (e.g. hyperlipidemia) were not included in our study. Another limitation is that only single time point measurements were available for statistical analysis which may have impaired its reliability. Therefore, a type-I error could not be excluded although the absence of any trend towards a difference argues against such a bias. Finally, it should be emphasized that BMI is not considered the optimal method for assessment of obesity in patients with kidney disease [19] . Waist circumference, waist-to-hip ratio, skinfold thickness and multifrequency body impedance analysis are considered better predictors of outcome in this setting [19] [20] [21] [22] [23] .
In summary, our study identifies overweight as a risk factor for increased atherosclerotic outcomes in a French hemodialysis population. The results of our study suggest that overweight should not be considered as a survival advantage or a protective factor in hemodialysis patients. We observed a linear relationship between body weight and AE in patients without MICS but not in those with MICS, in whom a Ucurve better described the relationship between weight and AE. Different phenotypes of obesity and adiposity measures as well as methodological factors could explain discrepancies between the results of the currently available studies. Further studies addressing these issues are clearly needed to more precisely assess the impact of overweight on AE in dialysis population.
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